A117 (Zolpidem tartrate extended release 6.25 mg)
Pill imprint A117 has been identified as Zolpidem tartrate extended release 6.25 mg.
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- A117
- Strength:
- 6.25 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Anchen Pharmaceuticals Inc.
- National Drug Code (NDC):
- 10370-0117
- Inactive Ingredients:
- silicon dioxide
hypromelloses
magnesium stearate
polyethylene glycol
sucrose
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
polyvinyl alcohol
magnesium silicate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 60429-0546 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about zolpidem
Consumer resources
- Zolpidem
- Zolpidem extended-release tablets
- Zolpidem spray
- Zolpidem (Advanced Reading)
- Zolpidem Oral, Oromucosal (Advanced Reading)
- Other brands: Ambien, Ambien CR, Intermezzo, Zolpimist, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
